acetaminophen has been researched along with HbS Disease in 17 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Excerpt | Relevance | Reference |
---|---|---|
"He had an upper respiratory tract infection in which a vaso-occlusive crisis was precipitated." | 5.34 | Tramadol infusion for the pain management in sickle cell disease: a case report. ( Aydinok, Y; Balkan, C; Erhan, E; Inal, MT; Yegul, I, 2007) |
" The mean total cumulative morphine dosing was 0." | 3.01 | Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises? ( Dhebaria, T; Sivitz, A; Tejani, C, 2021) |
"Sepsis is a heterogeneous clinical syndrome that is complicated commonly by acute kidney injury (sepsis-AKI)." | 2.66 | The Role of Circulating Cell-Free Hemoglobin in Sepsis-Associated Acute Kidney Injury. ( Kerchberger, VE; Ware, LB, 2020) |
"Evaluate the efficiency of the treatment of pain by analgesic according to World Health Organization (WHO)." | 1.35 | [Treatment of sickle cell pain]. ( Coulibaly, Y; Dembele, A; Diakite, AA; Dicko-Traore, F; Keita, MM; Sidibe, T; Sylla, M; Togo, B; Traore, B, 2009) |
"He had an upper respiratory tract infection in which a vaso-occlusive crisis was precipitated." | 1.34 | Tramadol infusion for the pain management in sickle cell disease: a case report. ( Aydinok, Y; Balkan, C; Erhan, E; Inal, MT; Yegul, I, 2007) |
"The gene for sickle cell disease is carried by 8% of the African-American population in the United States." | 1.28 | Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department. ( Pollack, CV; Sanders, DY; Severance, HW, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (11.76) | 18.7374 |
1990's | 3 (17.65) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 5 (29.41) | 2.80 |
Authors | Studies |
---|---|
Kerchberger, VE | 1 |
Ware, LB | 1 |
Dhebaria, T | 1 |
Sivitz, A | 1 |
Tejani, C | 1 |
Panda, PC | 1 |
Mishra, NR | 2 |
Patra, CS | 1 |
Nayak, BK | 1 |
Panda, SK | 1 |
Kumar, R | 1 |
Tripathy, SK | 1 |
Nasr, LA | 1 |
Haydar, AA | 1 |
Adam, AM | 1 |
Maritim, MC | 1 |
Diakite, AA | 1 |
Coulibaly, Y | 1 |
Dicko-Traore, F | 1 |
Traore, B | 1 |
Togo, B | 1 |
Dembele, A | 1 |
Sylla, M | 1 |
Sidibe, T | 1 |
Keita, MM | 1 |
Taha, HM | 1 |
Rehmani, RS | 1 |
Wong, F | 1 |
Erhan, E | 1 |
Inal, MT | 1 |
Aydinok, Y | 1 |
Balkan, C | 1 |
Yegul, I | 1 |
Agble, YM | 1 |
Séguier-Lipszyc, E | 1 |
de Lagausie, P | 1 |
Benkerrou, M | 1 |
Di Napoli, S | 1 |
Aigrain, Y | 1 |
Sanders, DY | 1 |
Severance, HW | 1 |
Pollack, CV | 1 |
Pegelow, CH | 1 |
Haddock, DR | 1 |
Bonotey-Ahulu, FI | 1 |
Janosi, M | 1 |
Ankra-Badu, G | 1 |
Reid, HA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Does IV Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises?[NCT03541980] | Phase 4 | 71 participants (Actual) | Interventional | 2018-02-20 | Completed | ||
A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis[NCT00094887] | Phase 2 | 150 participants (Actual) | Interventional | 2004-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Rate of adverse effects experienced by patients from opioid administration vs acetaminophen administration (NCT03541980)
Timeframe: 120 minutes
Intervention | Participants (Count of Participants) |
---|---|
Intervention | 0 |
Placebo | 0 |
Total dosing of opioid given after initial evaluation in mg/kg (NCT03541980)
Timeframe: 120 minutes
Intervention | mg/kg (Mean) |
---|---|
Intervention | .2 |
Placebo | .2 |
Percentage of patients admitted to the inpatient unit for parenteral pain management (NCT03541980)
Timeframe: 120 minutes
Intervention | Participants (Count of Participants) |
---|---|
Intervention | 25 |
Placebo | 21 |
Scale of 1-10 Pain scale, Min value 1, Max value 10, higher score is worse (NCT03541980)
Timeframe: at disposition
Intervention | pain intensity measured on scale 1-10 (Mean) |
---|---|
Intervention | 5.5 |
Placebo | 5.2 |
How satisfied were patients with the management of their pain (NCT03541980)
Timeframe: 120 minutes
Intervention | percent (Mean) |
---|---|
Intervention | 84 |
Placebo | 85 |
Length of hospitalization is defined as the length of time from admission to discharge order (NCT00094887)
Timeframe: within 40 days
Intervention | Days (Median) |
---|---|
Inhaled Nitric Oxide | 4.06 |
Placebo | 3.11 |
(NCT00094887)
Timeframe: within 24 hours
Intervention | Participants (Count of Participants) |
---|---|
Inhaled Nitric Oxide | 5 |
Placebo | 7 |
Number of participants who required a blood transfusion before discharge because of acute chest syndrome/pneumonia (NCT00094887)
Timeframe: within 40 days
Intervention | Participants (Count of Participants) |
---|---|
Inhaled Nitric Oxide | 8 |
Placebo | 7 |
"VOC resolution was defined by all of the following conditions:~Pain relief - Visual Analog Scale (VAS) pain scores of 6 or less, (6 as worst and 0 as best)~Freedom from parenteral narcotic use,~Ability to walk unless the subject was not able to walk for any reason other than acute VOC prior to the onset of crisis,~Subject and/or family's belief that the painful crisis could be managed at home with or without oral analgesic use, and the physician concurred with that assessment." (NCT00094887)
Timeframe: within 30 days
Intervention | Hours (Median) |
---|---|
Inhaled Nitric Oxide | 61.83 |
Placebo | 55.16 |
The number of participants readmitted to the hospital for any reason within 30 days after discharge (NCT00094887)
Timeframe: during first 24 hours and during 30 day follow-up
Intervention | Participants (Count of Participants) | |
---|---|---|
during first 24 hours | during 30-day follow-up | |
Inhaled Nitric Oxide | 0 | 9 |
Placebo | 0 | 17 |
The total dose (mg) of opioid medications received during the trial (NCT00094887)
Timeframe: within 8 hours and within 40 days
Intervention | mg (Median) | |
---|---|---|
within 8 hours | within 40 days | |
Inhaled Nitric Oxide | 16.25 | 153.75 |
Placebo | 17.25 | 211.37 |
2 reviews available for acetaminophen and HbS Disease
Article | Year |
---|---|
The Role of Circulating Cell-Free Hemoglobin in Sepsis-Associated Acute Kidney Injury.
Topics: Acetaminophen; Acute Kidney Injury; Anemia, Sickle Cell; Animals; Coronary Artery Bypass; Disseminat | 2020 |
Liver and kidney diseases.
Topics: Acetaminophen; Anemia, Sickle Cell; Animals; Aspirin; Cholestasis; Cysts; Glomerulonephritis, IGA; G | 2002 |
3 trials available for acetaminophen and HbS Disease
Article | Year |
---|---|
Does Intravenous Acetaminophen Reduce Opioid Requirement in Pediatric Emergency Department Patients With Acute Sickle Cell Crises?
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Analgesics, Opioid; Anemia, Sickle Cell; Child; | 2021 |
Intravenous Acetaminophen vs Intravenous Diclofenac Sodium in Management of Skeletal Vaso-occlusive Crisis Among Children with Homozygous Sickle Cell Disease: A Randomized Controlled Trial.
Topics: Acetaminophen; Anemia, Sickle Cell; Child; Diclofenac; Double-Blind Method; Humans; Pain Measurement | 2021 |
Thrombosis in sickle-cell pain crises? Controlled trial of ancrod (Arvin) in young adults.
Topics: Acetaminophen; Adolescent; Adult; Ampicillin; Anemia, Sickle Cell; Child; Chloroquine; Female; Fetal | 1973 |
12 other studies available for acetaminophen and HbS Disease
Article | Year |
---|---|
Intravenous Acetaminophen vs Intravenous Diclofenac in the Management of Painful Crisis in Sickle Cell Disease: Authors' Reply.
Topics: Acetaminophen; Administration, Intravenous; Anemia, Sickle Cell; Diclofenac; Humans; Pain | 2021 |
Intravenous Acetaminophen vs Intravenous Diclofenac in the Management of Painful Crisis in Sickle Cell Disease.
Topics: Acetaminophen; Administration, Intravenous; Anemia, Sickle Cell; Diclofenac; Humans; Pain | 2021 |
Plain film signs of sickle β-thalassaemia.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anemia, Sickle Cell; beta-Thalassemia; Female; Hemat | 2017 |
Pseudoxanthoma elasticum in a patient with sickle cell disease: case report.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Anemia, Sickle Cell; Anti-Bacterial Agents; Cef | 2008 |
[Treatment of sickle cell pain].
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Anemia, Sickle Cell; Child; Female; Humans; Mal | 2009 |
Pain management of children and adolescents with sickle cell disease presenting to the emergency department.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Analgesics, Opioid; Anemia, Sickle Cell; Anti-I | 2011 |
Tramadol infusion for the pain management in sickle cell disease: a case report.
Topics: Abdominal Pain; Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Anemia, Sickle Cell; Ch | 2007 |
Management of sickle cell disease. Non-addictive analgesics can be as effective as morphine and pethidine.
Topics: Acetaminophen; Analgesics, Opioid; Anemia, Sickle Cell; Child; Child, Preschool; Codeine; Drug Combi | 1998 |
Elective laparoscopic cholecystectomy.
Topics: Abdominal Pain; Acetaminophen; Acute Disease; Anemia, Sickle Cell; Child; Child, Preschool; Cholecys | 2001 |
Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department.
Topics: Acetaminophen; Adolescent; Adult; Amitriptyline; Analgesics; Anemia, Sickle Cell; Anti-Inflammatory | 1992 |
Survey of pain management therapy provided for children with sickle cell disease.
Topics: Acetaminophen; Analgesics; Anemia, Sickle Cell; Child; Child, Preschool; Codeine; Drug Administratio | 1992 |
Pain-relief in sickle cell crisis.
Topics: Acetaminophen; Analgesics; Anemia, Sickle Cell; Bone and Bones; Child; Humans; Pain; Recurrence | 1986 |